320 related articles for article (PubMed ID: 8896509)
1. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections.
Hawes SE; Hillier SL; Benedetti J; Stevens CE; Koutsky LA; Wolner-Hanssen P; Holmes KK
J Infect Dis; 1996 Nov; 174(5):1058-63. PubMed ID: 8896509
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen peroxide producing lactobacilli in women with vaginal infections.
Mijac VD; Dukić SV; Opavski NZ; Dukić MK; Ranin LT
Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):69-76. PubMed ID: 16814920
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen Peroxide-Producing Lactobacilli Are Associated With Lower Levels of Vaginal Interleukin-1β, Independent of Bacterial Vaginosis.
Mitchell C; Fredricks D; Agnew K; Hitti J
Sex Transm Dis; 2015 Jul; 42(7):358-63. PubMed ID: 26222747
[TBL] [Abstract][Full Text] [Related]
4. Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.
McClelland RS; Richardson BA; Hassan WM; Chohan V; Lavreys L; Mandaliya K; Kiarie J; Jaoko W; Ndinya-Achola JO; Baeten JM; Kurth AE; Holmes KK
J Infect Dis; 2008 May; 197(10):1361-8. PubMed ID: 18444793
[TBL] [Abstract][Full Text] [Related]
5. A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology.
Cherpes TL; Hillier SL; Meyn LA; Busch JL; Krohn MA
Sex Transm Dis; 2008 Jan; 35(1):78-83. PubMed ID: 17989585
[TBL] [Abstract][Full Text] [Related]
6. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition.
Martin HL; Richardson BA; Nyange PM; Lavreys L; Hillier SL; Chohan B; Mandaliya K; Ndinya-Achola JO; Bwayo J; Kreiss J
J Infect Dis; 1999 Dec; 180(6):1863-8. PubMed ID: 10558942
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with absence of H2O2-producing Lactobacillus among women with bacterial vaginosis.
Beigi RH; Wiesenfeld HC; Hillier SL; Straw T; Krohn MA
J Infect Dis; 2005 Mar; 191(6):924-9. PubMed ID: 15717268
[TBL] [Abstract][Full Text] [Related]
8. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis.
McLEAN NW; Rosenstein IJ
J Med Microbiol; 2000 Jun; 49(6):543-552. PubMed ID: 10847208
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women.
Baeten JM; Hassan WM; Chohan V; Richardson BA; Mandaliya K; Ndinya-Achola JO; Jaoko W; McClelland RS
Sex Transm Infect; 2009 Sep; 85(5):348-53. PubMed ID: 19329442
[TBL] [Abstract][Full Text] [Related]
10. Randomized Trial of Periodic Presumptive Treatment With High-Dose Intravaginal Metronidazole and Miconazole to Prevent Vaginal Infections in HIV-negative Women.
McClelland RS; Balkus JE; Lee J; Anzala O; Kimani J; Schwebke J; Bragg V; Lensing S; Kavak L
J Infect Dis; 2015 Jun; 211(12):1875-82. PubMed ID: 25526757
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana.
Konadu DG; Owusu-Ofori A; Yidana Z; Boadu F; Iddrisu LF; Adu-Gyasi D; Dosoo D; Awuley RL; Owusu-Agyei S; Asante KP
BMC Pregnancy Childbirth; 2019 Sep; 19(1):341. PubMed ID: 31547803
[TBL] [Abstract][Full Text] [Related]
12. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
van de Wijgert J; Verwijs MC
BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
[TBL] [Abstract][Full Text] [Related]
13. The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women.
Hillier SL; Krohn MA; Rabe LK; Klebanoff SJ; Eschenbach DA
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S273-81. PubMed ID: 8324131
[TBL] [Abstract][Full Text] [Related]
14. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
[TBL] [Abstract][Full Text] [Related]
15. Bacterial vaginosis, vulvovaginal candidiasis and trichomonal vaginitis among reproductive-aged women seeking primary healthcare in Sana'a city, Yemen.
Abdul-Aziz M; Mahdy MAK; Abdul-Ghani R; Alhilali NA; Al-Mujahed LKA; Alabsi SA; Al-Shawish FAM; Alsarari NJM; Bamashmos W; Abdulwali SJH; Al Karawani M; Almikhlafy AA
BMC Infect Dis; 2019 Oct; 19(1):879. PubMed ID: 31640583
[TBL] [Abstract][Full Text] [Related]
16. The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women.
Hillier SL; Krohn MA; Klebanoff SJ; Eschenbach DA
Obstet Gynecol; 1992 Mar; 79(3):369-73. PubMed ID: 1738516
[TBL] [Abstract][Full Text] [Related]
17. α-Amylase in Vaginal Fluid: Association With Conditions Favorable to Dominance of Lactobacillus.
Nasioudis D; Beghini J; Bongiovanni AM; Giraldo PC; Linhares IM; Witkin SS
Reprod Sci; 2015 Nov; 22(11):1393-8. PubMed ID: 25878210
[TBL] [Abstract][Full Text] [Related]
18. Bacterial vaginosis, vulvovaginal candidiasis, and trichomonal vaginitis in reproductive-age women in Yunnan, China: a descriptive study.
Zhao T; Xiao X; Xiao L; Wu XM; Yuan T
J Obstet Gynaecol; 2022 Oct; 42(7):3187-3192. PubMed ID: 35947028
[TBL] [Abstract][Full Text] [Related]
19. The role of lactobacilli and probiotics in maintaining vaginal health.
Borges S; Silva J; Teixeira P
Arch Gynecol Obstet; 2014 Mar; 289(3):479-89. PubMed ID: 24170161
[TBL] [Abstract][Full Text] [Related]
20. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida.
Strus M; Kucharska A; Kukla G; Brzychczy-Włoch M; Maresz K; Heczko PB
Infect Dis Obstet Gynecol; 2005 Jun; 13(2):69-75. PubMed ID: 16011996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
